Steve H Thorne

Title: Innovations by Steve H Thorne in Cancer Treatment

Introduction

Steve H Thorne is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of cancer treatment through his innovative work with altered poxviruses. With a total of 2 patents, Thorne's inventions focus on developing effective therapeutic agents for combating cancer.

Latest Patents

Thorne's latest patents revolve around methods and compositions concerning poxviruses and cancer. The inventions detail the use of altered poxviruses, including a modified vaccinia virus, to create more effective treatments for cancer and cancer cells. These poxviruses are engineered to be attenuated, meaning they are weakened in their ability to affect normal cells. The patents also describe methods that involve poxviruses with mutations that diminish or eliminate their capability to trigger an antiviral response in a host. This innovative approach aims to enhance the effectiveness of cancer treatments.

Career Highlights

Throughout his career, Thorne has worked with notable companies in the biotherapeutics sector. He has been associated with Sillajen Biotherapeutics, Inc. and Jennerex, Inc., where he has contributed to advancing cancer treatment technologies. His work has been pivotal in the development of novel therapeutic strategies.

Collaborations

Thorne has collaborated with various professionals in the field, including David H Kirn, enhancing the impact of his research and innovations.

Conclusion

Steve H Thorne's contributions to cancer treatment through his innovative patents highlight the potential of altered poxviruses as therapeutic agents. His work continues to pave the way for advancements in cancer therapies, showcasing the importance of innovation in medical science.